NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.
Frequently asked questions
What sector does Nanologix Inc (NNLX) operate in?
Nanologix Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Nanologix Inc (NNLX) current stock price?
As of the latest data, Nanologix Inc stock price is $0.00, with a previous close of $0.00.
What is Nanologix Inc (NNLX) current market capitalization?
Nanologix Inc market cap is approximately 15.88 thousand.
What is Nanologix Inc (NNLX) Earnings Per Share (EPS)?
The trailing EPS is -$0.02.
Does Nanologix Inc (NNLX) pay dividends?
No. Nanologix Inc does not pay a dividend.
What is Nanologix Inc (NNLX) beta (volatility) score?
Nanologix Inc has a beta of -99.376, indicating lower volatility than the overall market.